Tissue factor expression and multidrug resistance in cancer: two aspects of a common cellular response to a hostile milieu

被引:14
作者
Lwaleed, BA
Cooper, AJ
机构
[1] Univ Portsmouth, Dept Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England
[2] Southampton Univ Hosp, Dept Urol, MDR Res Grp, Southampton, Hants, England
[3] Southampton Univ Hosp, Dept Surg, MDR Res Grp, Southampton, Hants, England
关键词
D O I
10.1054/mehy.2000.1093
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tissue factor (TF) is the main physiological initiator of blood coagulation and its activation or de-encryption within plasma membranes is important for trapping, extravasation and angiogenesis in the development and spread of solid malignancies. Multidrug resistance is also an adaptive response in malignant (and normal) cells. It is often mediated by the over-expression of the P-glycoprotein (P-gP) efflux pump. Both TF and P-gP tend to be expressed together, perhaps as part of a coherent 'crisis management' response of cells to environmental change or challenge. An associated feature in such a response appears to be the reversal of normal phospholipid charge asymmetry in the plasma membrane bilayer. Responses to environmental stimuli affect function in normal and malignant tissue. Uniting the study of TF expression or de-encryption and MDR-1 phenotype would be biologically enlightening and might ultimately influence clinical cancer management and the control of thrombotic problems associated with treatment. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:470 / 473
页数:4
相关论文
共 40 条
[31]  
Ruf W, 1996, Curr Opin Hematol, V3, P379
[32]  
SATTA N, 1994, J IMMUNOL, V153, P3245
[33]  
SCARPATI EM, 1989, J BIOL CHEM, V264, P20705
[34]   The P-glycoprotein efflux pump: How does it transport drugs? [J].
Sharom, FJ .
JOURNAL OF MEMBRANE BIOLOGY, 1997, 160 (03) :161-175
[35]   NEW INSIGHTS INTO THE PATHOGENESIS OF COAGULATION DYSFUNCTION IN ACUTE PROMYELOCYTIC LEUKEMIA [J].
TALLMAN, MS ;
HAKIMIAN, D ;
KWAAN, HC ;
RICKLES, FR .
LEUKEMIA & LYMPHOMA, 1993, 11 (1-2) :27-36
[36]   CELLULAR-LOCALIZATION OF THE MULTIDRUG-RESISTANCE GENE-PRODUCT P-GLYCOPROTEIN IN NORMAL HUMAN-TISSUES [J].
THIEBAUT, F ;
TSURUO, T ;
HAMADA, H ;
GOTTESMAN, MM ;
PASTAN, I ;
WILLINGHAM, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7735-7738
[37]   Effect of tissue factor deficiency on mouse and tumor development [J].
Toomey, JR ;
Kratzer, KE ;
Lasky, NM ;
Broze, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6922-6926
[38]   MODULATION OF TISSUE FACTOR ON HUMAN MONOCYTES BY CISPLATIN AND ADRIAMYCIN [J].
WALSH, J ;
WHEELER, HR ;
GECZY, CL .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (04) :480-488
[39]  
WEISS RB, 1981, CANCER TREAT REP, V65, P677
[40]  
WIGGINS R, 1987, LAB INVEST, V56, P264